Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NKGen Biotech ( (NKGN) ) just unveiled an announcement.
On May 14, 2025, NKGen Biotech, Inc. entered into a Stock Purchase Agreement with CFIC-2015 NV Family Investments, LLC to issue and sell 19,669,552 shares of common stock at a price of $0.1271 per share, totaling $2,500,000. The agreement also includes a warrant for the purchaser to buy an additional 39,339,103 shares. This transaction, relying on exemptions from registration under the Securities Act, highlights NKGen Biotech’s strategic financial maneuvers to bolster its capital structure.
More about NKGen Biotech
NKGen Biotech, Inc. operates in the biotechnology industry, focusing on the development and commercialization of innovative therapies.
Average Trading Volume: 2,381,007
Technical Sentiment Signal: Sell
Current Market Cap: $13.48M
Learn more about NKGN stock on TipRanks’ Stock Analysis page.